Here at EverSmoke, we don’t promote our electronic cigarettes as a way to help quit smoking. Nevertheless, we are pleased when someone considers us as an alternative to traditional cigarettes. But not everyone is happy about this…
Recently, a story emerged about how big pharma is getting very concerned over the fact that so many people are using electronic smoking alternatives instead of the traditional patches and gum to cease the habit.
An article on a popular e-cigarette blog states that Andrew Witty, a GlaxoSmithKline Representative, recently mentioned that his company was considering another type of smoking alternative to compete with electronic cigarettes. At one point, the company discussed inventing their own version of an electronic cigarette, but the idea was tabled for now until they are able to see what the future holds.
“Even with an abundance of evidence to suggest that e-cigs are the best avenue for smokers that want to quit,” Witty says electronic smoking remains too controversial, so GlaxoSmithKline will continue to offer traditional smoking cessation alternatives such as nicotine patches and gum.
However, many electronic cigarette manufacturers paint an entirely different picture of big pharma’s involvement in the growing electronic smoking movement than Witty suggests.
According to some, the real foe of electronic cigarettes isn’t Big Tobacco, but Big Pharma itself. As the Washington Examiner reported:
“No industry spends more on lobbying in the U.S. than the drug industry, and drugmakers’ agendas are often bigger government. Big Pharma’s shadow hangs over the rule-making [of e-cigs].”
Again, we at EverSmoke don’t promote our products as a way to kick the habit, but we do welcome you to consider our electronic cigarettes as an alternative to traditional cigarettes.
If you are looking for a change, check out our blog post titled Vape Your Way to Better Shape! Also, feel free to browse our knowledge center for more info about the harmful effects of smoking, including 5 ways smoking affects your body.